"While we treat all types of cancer in League City, the faculty here has particular expertise in the diagnosis, treatment and management of the following: Breast Colorectal Dermatology and skin Endocrine Genitourinary Gynecologic Head and neck Neurologic Thoracic League City also offers the following treatment support services: Diagnostic imaging On-site outpatient lab services Rehabilitation therapy Cancer pain management Social work Access to clinical trials Clinical nutrition Genetic counseling Plastics and reconstructive surgery Oncology nurse navigator services If you have been diagnosed with cancer, we’re here to help."

During the past decade, MD Anderson League City conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 8 clinical trials were completed, i.e. on average, 21.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson League City" #1 sponsor was "M.D. Anderson Cancer Center" with 20 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NRG Oncology" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson League City" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson League City" are "Invasive Breast Carcinoma" (7 trials), "Triple-Negative Breast Carcinoma" (5 trials), "Stage II Breast Cancer AJCC v6 and v7" (4 trials), "Advanced Malignant Solid Neoplasm" (3 trials) and "Breast Carcinoma" (3 trials). Many other conditions were trialed in "MD Anderson League City" in a lesser frequency.

Most popular intervention types in "MD Anderson League City" are "Other" (43 trials), "Drug" (36 trials), "Procedure" (23 trials), "Radiation" (23 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (19 trials), "Questionnaire Administration" (14 trials), "Biospecimen Collection" (10 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson League City" are 33 trials for "All" genders, 20 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson League City". undefined are not yet recruiting, 26 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MD Anderson League City, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson League City, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".